For more than two years it had the entirety of the market for weight-loss drugs to itself. By 2023 sales of Wegovy had ...
Eli Lilly could extend its lead in its core therapeutic area with the launch of two new products next year. The company also ...
Shares of Eli Lilly & Co. rose 3.38% to $1,062.19 Monday, on what proved to be an all-around grim trading session for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback